- Home
- MUE vs HRTX Comparison
MUE vs HRTX Comparison
Compare MUE & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUE
- HRTX
- Stock Information
- Founded
- MUE 1999
- HRTX 1983
- Country
- MUE United States
- HRTX United States
- Employees
- MUE N/A
- HRTX N/A
- Industry
- MUE Investment Bankers/Brokers/Service
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- MUE Finance
- HRTX Health Care
- Exchange
- MUE Nasdaq
- HRTX Nasdaq
- Market Cap
- MUE 228.2M
- HRTX 270.7M
- IPO Year
- MUE N/A
- HRTX 1987
- Fundamental
- Price
- MUE $10.35
- HRTX $1.73
- Analyst Decision
- MUE
- HRTX Strong Buy
- Analyst Count
- MUE 0
- HRTX 3
- Target Price
- MUE N/A
- HRTX $5.67
- AVG Volume (30 Days)
- MUE 62.6K
- HRTX 1.2M
- Earning Date
- MUE 01-01-0001
- HRTX 02-27-2025
- Dividend Yield
- MUE 4.09%
- HRTX N/A
- EPS Growth
- MUE N/A
- HRTX N/A
- EPS
- MUE N/A
- HRTX N/A
- Revenue
- MUE N/A
- HRTX $137,737,000.00
- Revenue This Year
- MUE N/A
- HRTX $13.10
- Revenue Next Year
- MUE N/A
- HRTX $14.03
- P/E Ratio
- MUE N/A
- HRTX N/A
- Revenue Growth
- MUE N/A
- HRTX 12.13
- 52 Week Low
- MUE $8.53
- HRTX $1.04
- 52 Week High
- MUE $10.17
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- MUE 54.87
- HRTX 52.86
- Support Level
- MUE $10.26
- HRTX $1.63
- Resistance Level
- MUE $10.48
- HRTX $1.83
- Average True Range (ATR)
- MUE 0.08
- HRTX 0.10
- MACD
- MUE 0.00
- HRTX -0.01
- Stochastic Oscillator
- MUE 64.87
- HRTX 41.94
About MUE Blackrock MuniHoldings Quality Fund II Inc.
BlackRock MuniHoldings Quality Fund II Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. The fund seeks to achieve its investment objective by investing in long-term, investment-grade municipal obligations exempt from U.S. federal income taxes.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.